Inventor
BRINER KARIN
US15 patents
⚠️ This page may combine multiple inventors who share the name “BRINER KARIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
11 patentsUS7045545B1May 16, 2006
Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists
LILLY CO ELI12 citations82
US6967201B1Nov 22, 2005
Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
LILLY CO ELI15 citations81
US6638936B1Oct 28, 2003
Benzofurylpiperazine serotonin agonists
LILLY CO ELI15 citations81
US7186715B2Mar 6, 2007
Piperazine- and piperidine-derivatives as melanocortin receptor agonists
LILLY CO ELI6 citations71
US7169777B2Jan 30, 2007
Melanocortin receptor agonists
LILLY CO ELI8 citations71
US7157463B2Jan 2, 2007
Substituted piperidines/piperazines as melanocortin receptor agonists
LILLY CO ELI3 citations60
US8022062B2Sep 20, 2011
6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
LILLY CO ELI4 citations59
US7291619B2Nov 6, 2007
Melanocortin receptor agonists
LILLY CO ELI2 citations59
US6881733B1Apr 19, 2005
Serotonergic benzofurans
LILLY CO ELI0 citations39
US7981882B2Jul 19, 2011
6-N-linked heterocycle-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
LILLY CO ELI0 citations38
US7994163B2Aug 9, 2011
6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
LILLY CO ELI0 citations36
NOVARTIS AG
2 patentsUS11813306B2Nov 14, 2023
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
NOVARTIS AG0 citations56
US11026993B2Jun 8, 2021
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
NOVARTIS AG0 citations55